載入...
Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis
This article will review current treatment options for multiple sclerosis (MS) while keeping our primary focus on alemtuzumab, as it is now approved in more than 65 countries. From a pathophysiological point of view, MS is a disabling disease impacting a patient's life both physically and menta...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7948316/ https://ncbi.nlm.nih.gov/pubmed/33728194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13246 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|